HLS Therapeutics Inc. Stock Forecast
Stronger technical forecast for HLS Therapeutics Inc. stock price after Friday trading.
(Updated on May 03, 2024)
The HLS Therapeutics Inc. stock price gained 2.15% on the last trading day (Friday, 3rd May 2024), rising from $4.65 to $4.75. During the last trading day the stock fluctuated 1.06% from a day low at $4.70 to a day high of $4.75. The price has been going up and down for this period, and there has been a -4.04% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 thousand more shares were traded than the day before. In total, 2 thousand shares were bought and sold for approximately $9.03 thousand.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 19.41% during the next 3 months and, with a 90% probability hold a price between $4.77 and $6.43 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
HLS.TO Signals & Forecast
The HLS Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.68 and $4.48. A breakdown below any of these levels will issue sell signals. HLS Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 12, 2024, and so far it has fallen -8.12%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for HLS Therapeutics Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $3.99 and $3.95. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, HLS Therapeutics Inc. finds support just below today's level at $3.99. If this is broken, then the next support from accumulated volume will be at $3.95 and $3.61.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0500 between high and low, or 1.06%. For the last week, the stock has had daily average volatility of 0.256%.
Our recommended stop-loss: $4.50 (-5.19%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 15 days ago.)
Trading Expectations (HLS.TO) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect HLS Therapeutics Inc. to open at $4.73, and during the day (based on 14 day Average True Range), to move between $4.61 and $4.89, which gives a possible trading interval of +/-$0.135 (+/-2.84%) up or down from last closing price. If HLS Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 5.68% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $4.99 (5.05%) than the support at $3.99 (16.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
HLS Therapeutics Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.250. We will update the financials statements for HLS Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.88% in the first trading day after earnings release.
Is HLS Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for HLS Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score: 2.961 Buy Candidate Upgraded
Predicted Opening Price for HLS Therapeutics Inc. of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $4.73 ( 0.351%) | $4.75 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HLS.TO
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 4.78 | 0.702 % | |
| R2 | 4.76 | 0.300 % | ||
| R1 | 4.75 | 0.0512 % | ||
| Current price: | 4.75 | |||
| Support | S1 | 4.71 | -0.753 % | |
| S2 | 4.70 | -1.00 % | ||
| S3 | 4.68 | -1.40 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 5.17 | 8.84 % | |
| R2 | 5.04 | 6.11 % | ||
| R1 | 4.99 | 5.05 % | ||
| Current price | 4.75 | |||
| Support | S1 | 3.99 | -16.00% | |
| S2 | 3.95 | -16.84% | ||
| S3 | 3.61 | -24.00% |
HLS Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Apr 27, 2023 | Apr 27, 2023 | Jun 15, 2023 | $0.0500 | 0.781% |
| 2 | Jan 30, 2023 | Jan 30, 2023 | Mar 15, 2023 | $0.0500 | 0.585% |
| 3 | Oct 28, 2022 | Oct 28, 2022 | Dec 15, 2022 | $0.0500 | 0.485% |
| 4 | May 04, 2022 | Jul 28, 2022 | Sep 15, 2022 | $0.0500 | 0.517% |
| 5 | Mar 21, 2022 | Apr 28, 2022 | Jun 15, 2022 | $0.0500 | 0.386% |
FAQ
Click here for our free guide on how to buy HLS Therapeutics Inc. Stock.
